ATOS - Atossa Genetics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

ATOS is currently covered by 3 analysts with an average price target of $21. This is a potential upside of $19.4 (1212.5%) from yesterday's end of day stock price of $1.6.

Our record on ATOS covers 5 analysts since 2008; 3 cover it today. Of the 34 price targets those analysts set on ATOS, 24 were reached (71%). The highest performance score on ATOS belongs to Edward Woo of Ascendiant: 7.51, with 8 of 13 targets met in 190 days on average. The latest calls: Edward Woo of Ascendiant updated the call with a Buy rating on 1 Oct 2026; Emily Bodnar of H.C. Wainwright cut the target to $25 from $105 with a Buy rating on 26 Mar 2026; Albert Lowe of Craig Hallum raised the target to $10 from $4.05 with a Buy rating on 12 Feb 2026. Figures as of 18 Nov 2026.

Atossa Genetics's activity chart (see below) currently has 43 price targets and 37 ratings on display. The stock rating distribution of ATOS is 100% BUY.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 79.39% of the time, taking 399.63 days on average.

Highest price target for ATOS is $25, Lowest price target is $10, average price target is $21.

Most recent stock forecast was given by EDWARD WOO from ASCENDIANT on 01-Oct-2026. First documented stock forecast 11-Oct-2018.

Best performing analysts who are covering ATOS - Atossa Genetics:

Jason Mccarthy Emily Bodnar Edward Woo Louise Chen Albert Lowe

Currently out of the existing stock ratings of ATOS, 5 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 17-Sep-2020

$24

1 months 20 days ago
(01-Oct-2026)

8/13 (61.54%)

$19.06 (385.83%)

190

Buy Since 12-Feb-2024

$25

$23.12 (1229.79%)

$7

7 months 26 days ago
(26-Mar-2026)

14/15 (93.33%)

$20.29 (430.79%)

444

Buy Since 05-Jun-2025

$10

$8.4 (525.00%)

$4.05

9 months 9 days ago
(12-Feb-2026)

1/2 (50%)

$6.06 (153.81%)

251

Buy Since 08-Sep-2023

2 years 5 months 1 days ago
(20-Jun-2024)

1/1 (100%)

$-7.5 (-60.00%)

885

Buy Since 11-Oct-2018

$60

$105

4 years 4 months 8 days ago
(13-Jul-2022)

3/5 (60%)

$44.25 (280.95%)

170

Show more analysts

Please expand the browser size to see the chart

What is ATOS (Atossa Genetics) average time for price targets to be met?

On average it took 400 days for the stock forecasts to be reached, with an average price target met ratio of 79.39%.

Which analyst most recently updated their price target on ATOS (Atossa Genetics)?

Edward Woo

Which analyst has the lowest performance score on ATOS (Atossa Genetics) with a proven track record?

ALBERT LOWE

Which analyst has the most public recommendations on ATOS (Atossa Genetics)?

Edward Woo works at ASCENDIANT and has 1 price targets and 0 ratings on ATOS

Which analyst is the currently most bullish on ATOS (Atossa Genetics)?

Jason Mccarthy with the highest potential upside of $58.4

Which analyst is the currently most reserved on ATOS (Atossa Genetics)?

Edward Woo with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?